FindTrial
Sign In

The Effect of Cilostazol in reducing venous anastomosis stenosis of upper extremity ArterioVenous Hemodialysis Graft – A triple-blinded Randomized controlled trial.

The Effect of Cilostazol in reducing venous anastomosis stenosis of upper extremity ArterioVenous Hemodialysis Graft – A triple-blinded Randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20190328003
Enrollment
30
Registered
2019-03-28
Start date
2019-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arteriovenous graft &#44

Interventions

pletaal SR 100 mg per capsule,corn powder white capsule number 2 200 mg
Active Comparator Drug,Placebo Comparator Drug
cilostasol,placebo

Sponsors

ramathibodi hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ESRD patient age 18-90 years need hemodialysis new created upper extremities Arteriovenous graft

Exclusion criteria

Exclusion criteria: active cardiac problem cilostazol drug allergy

Design outcomes

Primary

MeasureTime frame
venous anastomosis stenosis 1 ,3, 6 months ultrasound base—

Secondary

MeasureTime frame
patency 1 ,3, 6 months clinical,steal syndrome 1 ,3, 6 months clinical,complication 1 ,3, 6 months clinical—

Countries

thailand

Contacts

Public Contactchana pattarasuktawil

vascular and transplant unit , department of surgery , ramathibodi hospital

killsx.cbh@gmail.com0880042341

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026